Sionna Therapeutics, Inc. Common Stock (SION NASDAQ) stock market data APIs
$36.0226
-0.86(-2.4%)
as of February 6, 2026
Try our APIs with
free plan!
Sionna Therapeutics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; and SION-719 and SION-451, which are nucleotide-binding domain 1 stabilizers in Phase 1 trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Prev. Close
36.0226
Open
35.1588
High
38.4622
Low
34.8106
52 wk Range
7.255-45
Market Cap
1 612 M
Shares Outstanding
44 629 K
EPS
-0.46
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sionna Therapeutics, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sionna Therapeutics, Inc. Common Stock data using free add-ons & libraries
Get Sionna Therapeutics, Inc. Common Stock Fundamental Data
Sionna Therapeutics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -82 841 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.6
Get Sionna Therapeutics, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sionna Therapeutics, Inc. Common Stock News
New
Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares
Key Points Sionna Therapeutics' Chief Legal Officer sold 10,250 shares for over $400k on Dec. 5, 2025. The company's stock has performed strongly in its first year on the market. These 10 stocks coul...
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Sionna Therapeutics, Inc. WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the curr...
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
Key Points 33,356 shares sold for a transaction value of $1,486,009.80 on Dec. 24, 2025. Reducing total indirect ownership to 3,561,655 shares. All shares were disposed via indirect ownership through...
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
Key Points 33,356 shares sold for a transaction value of $1,486,009.80 on Dec. 24, 2025. Reducing total indirect ownership to 3,561,655 shares. All shares were disposed via indirect ownership through...
Get Sionna Therapeutics, Inc. Common Stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
